Catalog No.
YVV23407
Expression system
E. coli
Species
Influenza A virus (strain A/Goose/Guangdong/1/1996 H5N1 genotype Gs/Gd)
Protein length
[Gly21-Tyr151] & [Met1-Pro25]3
Predicted molecular weight
24.59 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P28307 & YP_308670.1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Matrix protein 2, Proton channel protein M2, M, Major curlin subunit, csgA, b1042, JW1025
In Vitro Culture for H5N1-Specific Duck T Cells and Detection of Immune Responses Using Intracellular Cytokine Staining Method., PMID:40522882
Immediate PB2-E627K amino acid substitution after single infection of highly pathogenic avian influenza H5N1 clade 2.3.4.4b in mice., PMID:40474192
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
First contact: an interdisciplinary guide into decoding H5N1 influenza virus interactions with glycosaminoglycans in 3D respiratory cell models., PMID:40444153
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021-2024., PMID:40439507
Altered germinal center responses in mice vaccinated with highly pathogenic avian influenza A(H5N1) virus., PMID:40435634
Phylogenetic Analysis and Spread of HPAI H5N1 in Middle Eastern Countries Based on Hemagglutinin and Neuraminidase Gene Sequences., PMID:40431745
Novel Minimal Absent Words Detected in Influenza A Virus., PMID:40431670
Pathogenicity and transmissibility of bovine-derived HPAI H5N1 B3.13 virus in pigs., PMID:40396285
Genetic diversity of A(H5N1) avian influenza viruses isolated from birds and seals in Russia in 2023., PMID:40369040
Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses., PMID:40365787
Unique phenomenon of H5 highly pathogenic avian influenza virus in China: co-circulation of Clade 2.3.4.4b H5N1 and H5N6 results in diversity of H5 Virus., PMID:40326336
Intranasally administered whole virion inactivated vaccine against clade 2.3.4.4b H5N1 influenza virus with optimized antigen and increased cross-protection., PMID:40320528
Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction., PMID:40315333
Severe Avian Influenza A H5N1 Clade 2.3.4.4b Virus Infection in a Human with Continuation of SARS-CoV-2 Viral RNAs., PMID:40303095
Pathogenic and Antigenic Analyses of H5N1 High Pathogenicity Avian Influenza Virus Isolated in the 2022/2023 Season From Poultry Farms in Izumi City, Japan., PMID:40302740
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype., PMID:40284987
Comparative Mutational Analysis and the Glycosylation Patterns of a Peruvian Isolated Avian Influenza A Virus H5N1: Exploring Possible Viral Spillover Events Within One Health Approach., PMID:40284894
Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data., PMID:40262547
Design, Synthesis and In Vivo Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus., PMID:40256578
Dairy cows develop protective immunity against reinfection with bovine H5N1 influenza virus., PMID:40247094
Safety and Immunogenicity of Poultry Vaccine for Protecting Critically Endangered Avian Species against Highly Pathogenic Avian Influenza Virus, United States., PMID:40233764
Avian influenza A(H5N6) virus detected during live-poultry market surveillance linked to a human infection in Changsha, China, from 2020 to 2023., PMID:40205236
A paper-based loop-mediated isothermal amplification assay for highly pathogenic avian influenza., PMID:40204842
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin., PMID:40192291
Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens., PMID:40181968
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2., PMID:40171981
Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models., PMID:40169649
Cats as sentinels of mammal exposure to H5Nx avian influenza viruses: a seroprevalence study, France, December 2023 to January 2025., PMID:40156347
Fluorescent Microsphere Immunoassay for Isotype-Specific H5N1 Antibody Detection in Serum and Milk Samples From Dairy Cattle: A Tool for Epidemiological Surveillance., PMID:40145266
Dose-Dependent Effect of DNA Vaccine pVAX-H5 Encoding a Modified Hemagglutinin of Influenza A (H5N8) and Its Cross-Reactivity Against A (H5N1) Influenza Viruses of Clade 2.3.4.4b., PMID:40143259
Exposure of Wild Mammals to Influenza A(H5N1) Virus, Alaska, USA, 2020-2023., PMID:40133065
Detection of antibodies against influenza A viruses in cattle., PMID:40130892
Cellular SLC35B4 promotes internalization during influenza A virus entry., PMID:40130891
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices., PMID:40128814
Unique immune and other responses of human nasal epithelial cells infected with H5N1 avian influenza virus compared to seasonal human influenza A and B viruses., PMID:40126073
Highly Pathogenic Avian Influenza Virus Exposure and Infection in Free-Ranging Bobcats (Lynx rufus) in New York, USA., PMID:40103422
Large-scale computational modelling of H5 influenza variants against HA1-neutralising antibodies., PMID:40101386
Visualizing and analyzing 3D biomolecular structures using Mol* at RCSB.org: Influenza A H5N1 virus proteome case study., PMID:40099807
Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines., PMID:40091614
Immune history shapes human antibody responses to H5N1 influenza viruses., PMID:40082696
One-pot synthesized three-way junction based multiple strand displacement amplification for sensitive assay of H5N1 DNA., PMID:40078160
Neutralizing Antibody Response to Influenza A(H5N1) Virus in Dairy Farm Workers, Michigan, USA., PMID:40053378
Cross-species and mammal-to-mammal transmission of clade 2.3.4.4b highly pathogenic avian influenza A/H5N1 with PB2 adaptations., PMID:40044729
Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice., PMID:40035774
Influenza A(H5N1) Immune Response among Ferrets with Influenza A(H1N1)pdm09 Immunity., PMID:40023796
Effect of Prior Influenza A(H1N1)pdm09 Virus Infection on Pathogenesis and Transmission of Human Influenza A(H5N1) Clade 2.3.4.4b Virus in Ferret Model., PMID:40023783
Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020., PMID:40008897
For research use only. Not for human or drug use.
